NOTE : Spam and/or promotional messages and comments containing links will be removed.Comments that are written in all caps and contain excessive use of symbols will be removed. Include punctuation and upper and lower cases. Racism, sexism and other forms of discrimination will not be tolerated. Avoid profanity, slander or personal attacks directed at an author or another user. Even negative opinions can be framed positively and diplomatically. Only post material that’s relevant to the topic being discussed.īe respectful. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. (LCI), New Age Beverages Corporation (NBEV), ProQR Therapeutics N.V. (ARRY), CareDx, Inc (CDNA), Denali Therapeutics Inc. Stocks on the long side included Amarin Corporation plc (AMRN), Array BioPharma Inc. The long-term channel target says it’s headed to 92-93. After the wedge formed this last week, it got very quiet on lower volume on Thursday, and then boom, it went straight up, popping 4.72, or 5.6%, to 88.51, on 3.7 million share. I’m still looking for this to make a move to 22 1/2-23 zone, and then 27 1/2-3/4. It popped out of a falling wedge or flag, gaining 1.73, or 10%, to 19.48, on 871,094 shares traded. First, it needs to retest the highs at 17 1/2-18, then head to 20. It needs to get a follow-through because Thursday’s high at 15.93 is where there’s resistance. (NASDAQ: ARRY), which we gave you as a swing, ran up and pulled back hard when the market did, and then reversed nicely with a big engulfing bar on Thursday, jumping 1.18, or 8%, to 15.71, on 2.7 million shares. ![]() ![]() I still like the overall look of it.Īrray BioPharma Inc. I need this to get through the 20 level, before it can make a run at 23 and 27 targets. Right now, it looks like resistance is at 19.98. What I’m worried about is that the pullback and reversal right near the support level and technical bounce-back. On Thursday, this stock closed up 1.60, or 10%, to 17.72, on 23.5 million shares. The volume was decent but not heavy, and the underlying technicals were just okay. In the last two days it has jumped from 13.56 to 19.20, almost 6 points, or 45%. It hit 23.34, rolled over and went down 10 points to 13.56. Amarin Corporation (NASDAQ: AMRN), which was obviously a buy for us at the 10 level back in September, ran up to both of the targets, but I was looking for more, 27 to be exact.
0 Comments
Leave a Reply. |